ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2318

Inflammatory Arthritis Patient Perspectives on Strategies to Support Medication Adherence: A Qualitative Study Using a Novel Group Exercise

Sharan K. Rai1, Pavandeep Mehat2, Anne Townsend3, Carlo Marra4, Harpreet Chhina5, Rhonda Shuckett6 and Mary A. De Vera2, 1Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, 2Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 3Medical School, University of Exeter, Exeter, United Kingdom, 4School of Pharmacy, Memorial University, St. John's, NF, Canada, 5Orthopedic Surgery, BC Children's Hospital, Vancouver, BC, Canada, 6Rheumatology, University of British Columbia, Vancouver, BC, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Compliance, Disease-modifying antirheumatic drugs, inflammatory arthritis, medication and qualitative

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Disappointing and inconsistent findings of adherence intervention research in inflammatory arthritis (IA) highlight the need for further work in designing interventions that promote and support treatment adherence. Patient-centered approaches to developing medication adherence interventions have shown promise in other chronic diseases, and may be particularly relevant in IA where they have scarcely been applied. We aimed to explore IA patients’ perspectives on strategies to support medication adherence.  

Methods: Individuals were eligible for the study if they: (1) had a rheumatologist-confirmed diagnosis of IA, (2) were taking a DMARD(s), and (3) could communicate in English. A novelty of our study, an experienced facilitator led participants through a group exercise where participants were asked to design a hypothetical tool(s)/aid(s) supporting medication use. Participants developed their tools individually using provided activity sheets and coloured cards corresponding to features of their tools, including (1) what (is your tool?), (2) how (does your tool work?), and (3) who (is there anybody who uses your tool with you?). They were then invited to share their tools with the group, and the facilitator used open-ended questions to promote discussion. In our qualitative analysis, we applied an iterative, thematic approach informed by aspects of grounded theory and using the constant comparison method. Three study team members independently read and annotated the transcripts, and after discussion agreed on an initial coding framework. Categories emerging from the focus groups were identified and collected under major thematic headings.

Results: Six focus groups were held with 4-6 participants each. Qualitative analyses resulted in the identification of three predominant emerging themes: (1) educational resources; (2) lifestyle modifications and adaptations; and (3) the journey of medication use. Educational resources encompassed communication with a healthcare provider (e.g., rheumatologist, pharmacist), patient group classes, pamphlets and written resources, eHealth/mHealth, and learning about medication side-effects. Lifestyle modifications and adaptations were comprised of physical reminders/prompts for medication use (e.g., blister packs, pill boxes), electronic alerts/reminders (e.g., smartphone apps), establishing a routine (e.g., taking medication with breakfast), and managing multiple medications. The journey of medication use encompassed the sequential process of patients learning about and gaining confidence in prescribed medications, and the subsequent integration of these medications into their daily life (“Once I know the med, once I’m confident in the med, it’s working, then I phase it into my lifestyle”).

Conclusion: To our knowledge, this is the first study to use a novel group exercise to explore patients’ perspectives on strategies to support medication use in IA. Both educational resources and lifestyle modifications/adaptations were paramount to medication use among IA patients. These findings have important implications for the development of patient-centered medications adherence interventions.


Disclosure: S. K. Rai, None; P. Mehat, None; A. Townsend, None; C. Marra, None; H. Chhina, None; R. Shuckett, None; M. A. De Vera, None.

To cite this abstract in AMA style:

Rai SK, Mehat P, Townsend A, Marra C, Chhina H, Shuckett R, De Vera MA. Inflammatory Arthritis Patient Perspectives on Strategies to Support Medication Adherence: A Qualitative Study Using a Novel Group Exercise [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/inflammatory-arthritis-patient-perspectives-on-strategies-to-support-medication-adherence-a-qualitative-study-using-a-novel-group-exercise/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammatory-arthritis-patient-perspectives-on-strategies-to-support-medication-adherence-a-qualitative-study-using-a-novel-group-exercise/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology